FDA Probes Yaz, Others Over Blood Clot Risks
By Richard Vanderford · May 31, 2011, 10:12 PM EDT
The U.S. Food and Drug Administration said Tuesday that it launched an investigation into whether birth control pills that contain drospirenone, like Bayer AG's Yasmin and Yaz, put users at increased...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login